40150dkk
-1,4 %
Date:2024-06-17Time:16:59:48Latest report:Q4-2023List:Large CapTicker:NSIS B
Market Cap:188 022 mdkkEnterprise Value:194 687 mdkkNet Sales:17 899 mdkkEarnings:3 024 mdkkEmployees:0ISIN:DK0060336014

Ratios

10-year key figure history for Novonesis turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Novonesis with index and moving average MA50 and MA200.

Stockprice:401,50
MA50:404,77
MA200:361,49
Price/MA200:11,1 %
RSI (14):40,1
Price/MA50:-0,8 %

Description

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company is the world leader in industrial enzymes and microbial solutions, with a near-50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, working across more than 30 research and development and application centers and 23 manufacturing sites.